Sinopharm Vaccine Gets WHO Backing, Facilitating Broader Use
source:
https://www.youtube.com/watch?v=GJWr4bObvMY
transcript:
This afternoon WHO gave emergency use listing to Sinopharm Beijing's COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality. This expands the list of vaccines that COVAX can buy and gives countries confidence to expedite their own regulatory approval and to import and administer a vaccine. The Strategic Advisory Group of Experts on immunization or SAGE(免疫战略咨询专家组) has also reviewed the available data and recommends the vaccine for adults 18 years and older with a two dose schedule. Vaccines remain a vital tool.